Skip to main content
SpringerLink
Log in

Cancer of the Larynx and Hypopharynx

  • Chapter
Radiation Oncology

Part of the book series: Medical Radiology ((Med Radiol Radiat Oncol))

  • 1992 Accesses

Abstract

Carcinomas of the larynx and hypopharynx tend to present as local-regional disease that often requires multidisciplinary management. Preservation of function, as well as anatomy, can be paramount in the decision-making process. This tends to favor radiation therapy in the selection process. Treatment can, and should, be tailored to match the virulence of individual tumors and the impact of such therapy on individual patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adelstein DJ, Li Y, Adams GL et al. (2003) An Intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 21:92–98

    Article  PubMed  Google Scholar 

  2. Allal AS, Miralbell R, Lehmann W et al. (1997) Effect of arytenoid sparing during radiation therapy of early stage glottic carcinoma. Radiother Oncol 43:63–65

    Article  PubMed  CAS  Google Scholar 

  3. Amdur RJ, Conine FE, Harris RD et al. (1995) Arytenoid sparing during irradiation of early stage vocal cord cancer. Int J Radiat Oncol Biol Phys 32:801–808

    PubMed  CAS  Google Scholar 

  4. Ang KK, Trotti A, Brown BW et al. (2001) Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 51:571–578

    PubMed  CAS  Google Scholar 

  5. Ang KK, Harris J, Garden AS et al. (2005) Concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: radiation therapy oncology group phase II trial 99–14. J Clin Oncol 23:3008–3015

    Article  PubMed  CAS  Google Scholar 

  6. Bernier J, Domenge C, Ozsahin M et al. (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350:1945–1952

    Article  PubMed  CAS  Google Scholar 

  7. Bernier J, Cooper JS, Pajak TF et al. (2005) Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (# 22931) and RTOG (# 9501). Head Neck 2005:843–850

    Article  Google Scholar 

  8. Blanco AI, Chao KS, El Naqa I et al. (2005) Dose-volume modeling of salivary function in patients with head-andneck cancer receiving radiotherapy. Int J Radiat Oncol Biol Phys 62:1055–1069

    PubMed  Google Scholar 

  9. Bonner JA, Harari PM, Giralt J et al. (2006) Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354:567–578

    Article  PubMed  CAS  Google Scholar 

  10. Brizel DM, Albers ME, Fisher SR et al. (1998) Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 338:1798–1804

    Article  PubMed  CAS  Google Scholar 

  11. Bussels B, Maes A, Flamen P et al. (2004) Dose-response relationships within the parotid gland after radiotherapy for head and neck cancer. Radiother Oncol 73:297–306

    Article  PubMed  Google Scholar 

  12. Chatani M, Matayoski Y, Masaki N et al. (1996) Radiation therapy for early glottic carcinoma (T1N0M0). The final results of prospective randomized study concerning radiation field. Strahlenther Onkol 172:169–172

    PubMed  CAS  Google Scholar 

  13. Cooper JS, Pajak TF, Rubin P et al. (1989) Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience. Int J Radiat Oncol Biol Phys 17:449–456

    PubMed  CAS  Google Scholar 

  14. Cooper JS, Pajak TF, Forastiere AA et al. (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350:1937–1944

    Article  PubMed  Google Scholar 

  15. Denham JW, Peters LJ, Johansen J et al. (1999) Do acute mucosal reactions lead to consequential late reactions in patients with head and neck cancer? Radiother Oncol 52:157–164

    Article  PubMed  CAS  Google Scholar 

  16. Department of Veterans Affairs Laryngeal Cancer Study Group (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324:1685–1690

    Google Scholar 

  17. Eisbruch A, Kim HM, Terrell JE et al. (2001) Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys 50:695–704

    PubMed  CAS  Google Scholar 

  18. Emami B, Lyman J, Brown A et al. (1991) Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21:109–122

    PubMed  CAS  Google Scholar 

  19. Forastiere AA, Goepfert H, Maor M et al. (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349:2091–2098

    Article  PubMed  CAS  Google Scholar 

  20. Fu KK, Pajak TF, Trotti A et al. (2000) A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 48:7–16

    Article  PubMed  CAS  Google Scholar 

  21. Garden AS, Forster K, Wong PF et al. (2003) Results of radiotherapy for T2N0 glottic carcinoma: does the “2” stand for twicedaily treatment? Int J Radiat Oncol Biol Phys 55:322–328

    PubMed  Google Scholar 

  22. Garden AS, Harris J, Vokes EE et al. (2004) Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase II trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck. J Clin Oncol 22:2856–2864

    Article  PubMed  CAS  Google Scholar 

  23. Gordin A, Daitzchman M, Doweck I et al. (2006) Fluorodeoxyglucose-positron emission tomography/computed tomography imaging in patients with carcinoma of the larynx: diagnostic accuracy and impact on clinical management. Laryngoscope 116:273–278

    Article  PubMed  Google Scholar 

  24. Greene F, Page D, Fleming I et al. (2002) AJCC Cancer Staging Manual, 6th edn. Springer, Berlin Heidelberg New York

    Google Scholar 

  25. Hinerman RW, Mendenhall WM, Amdur RJ et al. (2002) Carcinoma of the supraglottic larynx: treatment results with radiotherapy alone or with planned neck dissection. Head Neck 24:456–467

    Article  PubMed  Google Scholar 

  26. Jellema AP, Slotman BJ, Doornaert P et al. (2007) Unilateral versus bilateral irradiation in squamous cell head and neck cancer in relation to patient-rated xerostomia and sticky saliva. Radiother Oncol 85:83–89

    Article  PubMed  Google Scholar 

  27. Jeremic B, Djuric L, Mijatovic L (1991) Incidence of radiation myelitis of the cervical spinal cord at doses of 5500 cGy or greater. Cancer 68:2138–2141

    Article  PubMed  CAS  Google Scholar 

  28. Kim RY, Marks ME, Salter MM (1992) Early-stage glottic cancer: importance of dose fractionation in radiation therapy. Radiology 182:273–275

    PubMed  CAS  Google Scholar 

  29. Le QT, Fu KK, Kroll S et al. (1997) Influence of fraction size, total dose, and overall time on local control of T1–T2 glottic carcinoma. Int J Radiat Oncol Biol Phys 39:115–126

    PubMed  CAS  Google Scholar 

  30. Lefebvre JL, Chevalier D, Luboinski B et al. (1996) Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 88:890–899

    Article  PubMed  CAS  Google Scholar 

  31. Marcus RB Jr, Million RR (1990) The incidence of myelitis after irradiation of the cervical spinal cord. Int J Radiat Oncol Biol Phys 19:3–8

    PubMed  Google Scholar 

  32. Mendenhall WM, Parsons JT, Million RR et al. (1988) T1–T2 squamous cell carcinoma of the glottic larynx treated with radiation therapy: relationship of dose-fractionation factors to local control and complications. Int J Radiat Oncol Biol Phys 15:1267–1273

    PubMed  CAS  Google Scholar 

  33. Mendenhall WM, Amdur RJ, Morris CG et al. (2001) T1–T2 N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy. J Clin Oncol 19:4029–4036

    PubMed  CAS  Google Scholar 

  34. Mendenhall WM, Werning W, Hinerman RW et al. (2004) Management of T1–T2 glottic carcinomas. Cancer 100:1786–1792

    Article  PubMed  Google Scholar 

  35. Merlano M (2006) Alternating chemotherapy and radiotherapy in locally advanced head and neck cancer: an alternative? Oncologist 11:146–151

    Article  PubMed  CAS  Google Scholar 

  36. Nakamura K, Shioyama Y, Kawashima M et al. (2006) Multiinstitutional analysis of early squamous cell carcinoma of the hypopharynx treated with radical radiotherapy. Int J Radiat Oncol Biol Phys 65:1045–1050

    PubMed  Google Scholar 

  37. gls/PDF/head-and-neck.pdf (Accessed on March 5, 2008)

    Google Scholar 

  38. Pignon JP, le Maître A, Bourhis J et al. (2007) MACH-NC Collaborative Group. Meta-Analyses of Chemotherapy in Head and Neck Cancer (MACH-NC): an update. Int J Radiat Oncol Biol Phys 69[2 Suppl]:S112–114

    Google Scholar 

  39. Ricciardelli EJ, Weymuller EA Jr, Koh WJ et al. (1994) Effect of radiation fraction size on local control rates for early glottic carcinoma. A model analysis for in vivo tumor growth and radio-response parameters. Arch Otolaryngol Head Neck Surg 120:737–742

    PubMed  CAS  Google Scholar 

  40. Roh JL, Pae KH, Choi SH et al. (2007) 2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography as guidance for primary treatment in patients with advanced-stage resectable squamous cell carcinoma of the larynx and hypopharynx. Eur J Surg Oncol 33:790–795

    PubMed  Google Scholar 

  41. Rovirosa A (1997) In relation to the arytenoid edema in the radiotherapy of the early vocal cord cancer: arytenoid shielding and small size of the field. Radiother Oncol 45:209–210

    Article  PubMed  CAS  Google Scholar 

  42. Rudoltz MS, Benammar A, Mohiuddin M (1993) Prognostic factors for local control and survival in T1 squamous cell carcinoma of the glottis. Int J Radiat Oncol Biol Phys 26:767–772

    PubMed  CAS  Google Scholar 

  43. Schwaibold F, Scariato A, Nunno M et al. (1998) The effect of fraction size on control of early glottic cancer. Int J Radiat Oncol Biol Phys 14:451–454

    Google Scholar 

  44. Schwartz DL, Rajendran J, Yueh B et al. (2004) FDG-PET prediction of head and neck squamous cell cancer outcomes. Arch Otolaryngol Head Neck Surg 130:1361–1367

    Article  PubMed  Google Scholar 

  45. Spector JG, Sessions DG, Chao KS et al. (1999) Stage I (T1 N0 M0) squamous cell carcinoma of the laryngeal glottis: therapeutic results and voice preservation. Head Neck 21:707–717

    Article  PubMed  CAS  Google Scholar 

  46. Staar S, Rudat V, Stuetzer H et al. (2001) Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy — results of a multicentric randomized German trial in advanced head and neck cancer. Int J Radiat Oncol Biol Phys 50:1161–1171

    PubMed  CAS  Google Scholar 

  47. Trotti A, Pajak T, Emami B et al. (2006) A randomized trial of hyperfractionation versus standard fractionation in T2 squamous cell carcinoma of the vocal cord. Int J Radiat Oncol Biol Phys 66:S15

    Google Scholar 

  48. Warde P, O’Sullivan B, Bristow RG et al. (1998) T1–T2 glottic cancer managed by external beam radiotherapy: the influence of pretreatment hemoglobin on local control. Int J Radiat Oncol Biol Phys 41:347–353

    PubMed  CAS  Google Scholar 

  49. Yamazaki H, Nishiyama K, Tanaka E et al. (2006) Radiotherapy for early glottic carcinoma (T1N0M0): results of prospective randomized study of radiation fraction size and overall treatment time. Int J Radiat Oncol Biol Phys 64:77–82

    PubMed  Google Scholar 

  50. Yu E, Shenouda G, Beaudet MP et al. (1997) Impact of radiation therapy fraction size on local control of early glottic carcinoma. Int J Radiat Oncol Biol Phys 37:587–591

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Maimonides Cancer Center, 6300 Eighth Avenue, Brooklyn, NY, 11220, USA

    Jay S. Cooper MD

Authors
  1. Jay S. Cooper MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Radiation Oncology National University Cancer Institute of Singapore National University Health System, National University of Singapore, 5 Lower Kent Ridge Road, Singapore, 119074, Singapore

    Jiade J. Lu MD, MBA (Associate Professor and Consultant and Distinguished Clinical Professor) (Associate Professor and Consultant and Distinguished Clinical Professor)

  2. Department of Radiation Oncology, Cancer Hospital of Fudan University, 270 Dong An Road, Shanghai, 200232, P.R. China

    Jiade J. Lu MD, MBA (Associate Professor and Consultant and Distinguished Clinical Professor) (Associate Professor and Consultant and Distinguished Clinical Professor)

  3. College of Medicine, Drexel University, Broad & Vine Sts., Mail Stop 200, Philadelphia, PA, 19102-1192, USA

    Luther W. Brady MD (Hylda Cohn/American Cancer Society Professor of Clinical Oncology, and Professor, Department of Radiation Oncology Distinguished University Professor) (Hylda Cohn/American Cancer Society Professor of Clinical Oncology, and Professor, Department of Radiation Oncology Distinguished University Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Cooper, J.S. (2008). Cancer of the Larynx and Hypopharynx. In: Lu, J.J., Brady, L.W. (eds) Radiation Oncology. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-77385-6_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-77385-6_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-77384-9

  • Online ISBN: 978-3-540-77385-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation